Physician profile
Juliet Wanjiru Kimathi
NPI 1538808316
$633.09
in general payments reported to CMS, 2019-2025
8 companies · $160 in 2025
The $160 reported for 2025 was more than what a typical Hospice and Palliative Medicine (Family Medicine) provider received nationally (typical 2025 total: $78.57).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $125 · 2023: $45.62 · 2024: $302 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $508.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $508.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $154.40 | 2024-2025 | Dovato, Apretude |
| Insulet Corporation | $130.80 | 2025 | Omnipod |
| Teva Pharmaceuticals USA, INC. | $124.99 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $123.50 | 2024 | Airsupra |
| Averitas Pharma INC. | $43.62 | 2023-2024 | Qutenza |
| Recordati_rare_diseases_inc. | $20.88 | 2024 | Signifor Lar, Isturisa |
| Exact Sciences Corporation | $19.75 | 2023 | Cologuard Collection Kit |
| Organon LLC | $15.15 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juliet Kimathi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.